BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pírez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A, Giachetto G, Montano A. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J 2014;33:753-9. [PMID: 24492286 DOI: 10.1097/INF.0000000000000294] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Bruhn CA, Schuck-Paim C, Kürüm E, Taylor RJ, Simonsen L, Weinberger DM. Improving Assessments of Population-level Vaccine Impact. Epidemiology 2017;28:233-6. [PMID: 27922531 DOI: 10.1097/EDE.0000000000000598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Alemu A, Singh M, Blumberg C, Richards JO, Oaks MK, Thompson MA. Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study. J Patient Cent Res Rev 2017;4:53-9. [PMID: 31413971 DOI: 10.17294/2330-0698.1415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Farkouh RA, Hall-Murray C, Klok RM, Hilton B, Isturiz RE. Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children". Infect Dis Ther 2015;4:227-33. [PMID: 25908483 DOI: 10.1007/s40121-015-0063-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Tan KK, Dang DA, Kim KH, Kartasasmita C, Kim HM, Zhang XH, Shafi F, Yu TW, Ledesma E, Meyer N. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea. Hum Vaccin Immunother 2018;14:95-105. [PMID: 29125809 DOI: 10.1080/21645515.2017.1375073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
5 Sartori AM, Nascimento Ade F, Yuba TY, Soárez PC, Novaes HM. Methods and challenges for the health impact assessment of vaccination programs in Latin America. Rev Saude Publica 2015;49:S0034-89102015000100410. [PMID: 26759964 DOI: 10.1590/S0034-8910.2015049006058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
6 Moreno-pérez D, Martín AA, García AT, Montaner AE, Mulet JF, García JG, Moreno-galdó A, de Liria CRG, Contreras JR, Lozano JS. Community acquired pneumonia in children: Outpatient treatment and prevention. Anales de Pediatría (English Edition) 2015;83:439.e1-7. [DOI: 10.1016/j.anpede.2014.10.011] [Reference Citation Analysis]
7 Ceyhan M, Aykac K, Gurler N, Ozsurekci Y, Öksüz L, Altay Akısoglu Ö, Öz FN, Emiroglu M, TurkDagi H, Yaman A, Söyletir G, Öztürk C, Akpolat N, Özakin C, Aydın F, Aydemir Ş, Kiremitci A, Gültekin M, Camcıoglu Y, Zer Y, Güdücüoğlu H, Gülay Z, Birinci A, Arabaci C, Karbuz A, Devrim I, Sorguc Y, Baysan BÖ, Karadag Oncel E, Yilmaz N, Altintop YA. Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018. Hum Vaccin Immunother 2020;16:2773-8. [PMID: 32530357 DOI: 10.1080/21645515.2020.1747931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lavi E, Breuer O. The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia. Curr Infect Dis Rep 2016;18:3. [PMID: 26715113 DOI: 10.1007/s11908-015-0509-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Shenoy AT, Orihuela CJ. Anatomical site-specific contributions of pneumococcal virulence determinants. Pneumonia (Nathan) 2016;8:7. [PMID: 27635368 DOI: 10.1186/s41479-016-0007-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
10 McCulloh RJ, Patel K. Recent Developments in Pediatric Community-Acquired Pneumonia. Curr Infect Dis Rep 2016;18:14. [PMID: 26960931 DOI: 10.1007/s11908-016-0521-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Shiragami M, Mizukami A, Leeuwenkamp O, Mrkvan T, Delgleize E, Kurono Y, Iwata S. Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children". Infect Dis Ther 2015;4:235-44. [PMID: 25908482 DOI: 10.1007/s40121-015-0062-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, Mortimer K, Asante KP, Balakrishnan K, Balmes J, Bar-Zeev N, Bates MN, Breysse PN, Buist S, Chen Z, Havens D, Jack D, Jindal S, Kan H, Mehta S, Moschovis P, Naeher L, Patel A, Perez-Padilla R, Pope D, Rylance J, Semple S, Martin WJ 2nd. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2014;2:823-60. [PMID: 25193349 DOI: 10.1016/S2213-2600(14)70168-7] [Cited by in Crossref: 402] [Cited by in F6Publishing: 213] [Article Influence: 50.3] [Reference Citation Analysis]
13 Schuck-Paim C, Taylor RJ, Simonsen L, Lustig R, Kürüm E, Bruhn CA, Weinberger DM. Challenges to estimating vaccine impact using hospitalization data. Vaccine 2017;35:118-24. [PMID: 27899227 DOI: 10.1016/j.vaccine.2016.11.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
14 Esposito S, Principi N. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children. J Immunol Res 2015;2015:591580. [PMID: 26351648 DOI: 10.1155/2015/591580] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
15 Chacon-Cruz E, Rivas-Landeros RM, Volker-Soberanes ML. Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital. Ther Adv Vaccines. 2014;2:155-158. [PMID: 25364508 DOI: 10.1177/2051013614547199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
16 DeAntonio R, Amador S, Bunge EM, Eeuwijk J, Prado-Cohrs D, Nieto Guevara J, Rubio MDP, Ortega-Barria E. Vaccination herd effect experience in Latin America: a systematic literature review. Hum Vaccin Immunother 2019;15:49-71. [PMID: 30230953 DOI: 10.1080/21645515.2018.1514225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study. PLoS One 2017;12:e0172690. [PMID: 28249015 DOI: 10.1371/journal.pone.0172690] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]